However, a similar correlation was not observed between the CSF Aβ42 levels and the MECP2 protein levels or the phosphorylation changes in MECP2, emphasizing that further studies are still needed in different cell types to delineate the role of MECP2 in the key pathophysiological processes in AD. This evidence concerns the gene MECP2 and Alzheimer disease.